Cheryl H. Baker

5.5k citations

66 papers · 4.5k indexed · h-index 36

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 14
Oncology top 2%
- Colorectal Cancer Treatments and Studies 6
Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 19
- PI3K/AKT/mTOR signaling in cancer 6
Internal Medicine top 5%
Immunology and Allergy top 5%
Materials Chemistry
- Advanced Nanomaterials in Catalysis 7
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 6
Genetics
- Glioma Diagnosis and Treatment 5
Biomedical Engineering
- Nanoplatforms for cancer theranostics 5

Co-authors: Jimmie Colón Isaiah J. Fidler Sudipta Seal James L. Abbruzzese Carmen C. Solórzano Maen Abdelrahim Patrick Kupelian Justin M. Summy
Cited by: Cancer Research Oncology Molecular Biology
Journals: Journal of Clinical Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Biochemistry (2 papers)
Partner nations: United States Australia Spain

In The Last Decade

Cheryl H. Baker

65 papers receiving 4.5k citations

Peers

Countries citing papers authored by Cheryl H. Baker

Since Specialization

Citations

This map shows the geographic impact of Cheryl H. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl H. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl H. Baker more than expected).

Fields of papers citing papers by Cheryl H. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl H. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl H. Baker. The network helps show where Cheryl H. Baker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cheryl H. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheryl H. Baker Line = papers co-authored together Cheryl H. Baker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Harnessing cerium oxide nanoparticles to protect normal tissue from radiation damage Translational Cancer Research ·Cheryl H. Baker	2013	24
2	Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production Nanomedicine Nanotechnology Biology and Medicine ·Melissa S. Wason,Jimmie Colón,Soumen Das,Sudipta Seal,James Turkson,Jihe Zhao,Cheryl H. Baker	2012	268
3	Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors Gynecologic Oncology ·Riyaz Basha,Susan B. Ingersoll,Umesh T. Sankpal,Sarfraz Ahmad,Cheryl H. Baker,John Edwards,Robert W. Holloway,Sumanth Kaja,Maen Abdelrahim	2011	48
4	A Facile Nanoparticle Immunoassay for Cancer Biomarker Discovery Journal of Nanobiotechnology ·Qun Huo,Jimmie Colón,Adam Cordero,Jelena Bogdanović Pristov,Cheryl H. Baker,Steven Goodison,Marianna Pensky	2011	51
5	A label-free nanoparticle aggregation assay for protein complex/aggregate detection and study Analytical Biochemistry ·Jelena Bogdanović Pristov,Jimmie Colón,Cheryl H. Baker,Qun Huo	2010	29
6	Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics Chemical Communications ·K. Suresh Babu,Jung Hyun Cho,Janet M. Dowding,Eric Heckert,Chris Komanski,Soumen Das,Jimmie Colón,Cheryl H. Baker,Michael Bass,William T. Self,Sudipta Seal	2010	112
7	Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression Molecular Cancer Therapeutics ·Santhi D. Konduri,Jimmie Colón,Cheryl H. Baker,Stephen Safe,James L. Abbruzzese,Ala Abudayyeh,Riyaz Basha,Maen Abdelrahim	2009	50
8	Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis Clinical Cancer Research ·Santhi D. Konduri,Jonathan Ticku,George C. Bobustuc,Robert M. Sutphin,Jimmie Colón,Beth Isley,Kishor K. Bhakat,Srivenugopal S. Kalkunte,Cheryl H. Baker	2009	28
9	Biomarkers clinical relevance in cancer: Emphasis on breast cancer and prostate cancer Current Trends in Biotechnology and Pharmacy ·Riyaz Basha,Cheryl H. Baker,Maen Abdelrahim	2009	1
10	Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice Investigational New Drugs ·Jimmie Colón,Riyaz Basha,Rafael Madero‐Visbal,Santhi D. Konduri,Cheryl H. Baker,Luis Javier Herrera,Stephen Safe,David Sheikh‐Hamad,Ala Abudayyeh,Beatrice Alvarado,Maen Abdelrahim	2009	56
11	Protection from radiation-induced pneumonitis using cerium oxide nanoparticles Nanomedicine Nanotechnology Biology and Medicine ·Jimmie Colón,Luis Javier Herrera,Joshua D. Smith,Swanand Patil,Chris Komanski,Patrick Kupelian,Sudipta Seal,D. Wayne Jenkins,Cheryl H. Baker	2009	247
12	A metastatic colon cancer model using nonoperative transanal rectal injection Surgical Endoscopy ·Melissa Donigan,Bryan D. Loh,Laurie S. Norcross,Shuan Li,Paul Williamson,Samuel DeJesus,Andrea Ferrara,Joseph Gallagher,Cheryl H. Baker	2009	20
13	A new murine model for colon cancer using non-operative trans-anal rectal injection Cancer Research ·Laurie S. Norcross,Melissa Donigan,John G. Aversa,Rafael Madero‐Visbal,Jimmie Colón,Joshua Smith,Renee Mueller,Paul Williamson,Samuel DeJesus,Andrea Ferrara,Joseph Gallagher,Cheryl H. Baker	2008	1
14	Selective radioprotection of normal tissues by new cerium oxide nanoparticles Cancer Research ·Jimmie Colón,Sudipta Seal,Santhi D. Konduri,Arati Limaye,Maen Abdelrahim,Cheryl H. Baker	2007	1
15	Noninvasive Bioluminescence Imaging of Luciferase Expressing Intracranial U87 Xenografts: Correlation with Magnetic Resonance Imaging Determined Tumor Volume and Longitudinal Use in Assessing Tumor Growth and Antiangiogenic Treatment Effect Neurosurgery ·Oszkar Szentirmai,Cheryl H. Baker,Ning Lin,Szofia Szucs,Masaya Takahashi,Shigeru Kiryu,Andrew L. Kung,Richard C. Mulligan,Bob S. Carter	2006	101
16	Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors Neoplasia ·Cheryl H. Baker,Maria Simona Pino,Isaiah J. Fidler	2006	16
17	A Phase II Study of Rebeccamycin Analog NSC 655649 in Patients with Metastatic Colorectal Cancer Investigational New Drugs ·Sanjay Goel,Scott Wadler,Anthony Hoffman,Fabio Volterra,Cheryl H. Baker,Elliot Nazario,Percy Ivy,Alyson Silverman,Sridhar Mani	2003	19
18	Phase I Clinical Trial of Irinotecan With Oral Capecitabine in Patients With Gastrointestinal and Other Solid Malignancies American Journal of Clinical Oncology ·Sanjay Goel,Minaxi Jhawer,Lakshmi Rajdev,Una Hopkins,Karen Fehn,Cheryl H. Baker,Hoo G. Chun,Della Makower,Leon Landau,Anthony Hoffman,Scott Wadler,Sridhar Mani	2002	9
19	Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human Carcinomas American Journal Of Pathology ·Cheryl H. Baker,Daniel Kedar,Marya F. McCarty,Rachel Tsan,Kristen L. Weber,Corazon D. Bucana,Isaiah J. Fidler	2002	113
20	Inhibition of Growth and Metastasis of Human Pancreatic Cancer Growing in Nude Mice by PTK 787/ZK222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases Cancer Biotherapy and Radiopharmaceuticals ·Carmen C. Solórzano,Cheryl H. Baker,Christiane J. Bruns,Jerald J. Killion,Lee M. Ellis,Jeanette M. Wood,Isaiah J. Fidler	2001	103

About Cheryl H. Baker

Cheryl H. Baker is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 66 papers that have together received 4.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (19 papers), Cancer, Hypoxia, and Metabolism (14 papers), Advanced Nanomaterials in Catalysis (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Glioma Diagnosis and Treatment (5 papers) and Nanoplatforms for cancer theranostics (5 papers). The work is most often cited by research in Cancer Research (850 citations), Oncology (1.4k citations) and Molecular Biology (2.1k citations). Cheryl H. Baker has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Jimmie Colón, Isaiah J. Fidler, Sudipta Seal, James L. Abbruzzese, Carmen C. Solórzano, Maen Abdelrahim, Patrick Kupelian, Justin M. Summy, Stephen Safe and Gary E. Gallick. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact